Home » GeoPharma Gets $2.5 Million for Cancer Business
GeoPharma Gets $2.5 Million for Cancer Business
GeoPharma Inc. signed an agreement to sell a 60 percent stake in its ovarian cancer business to Trident Biotech Inc.
Tampa Bay Business Journal
Tampa Bay Business Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May